AstraZeneca
Apolipoprotein risk factors for CVD reviewed
Published in Cardiovascular Device Liability Week, March 21st, 2004
"Although LDL cholesterol (LDL-C) is associated with an increased risk of coronary heart disease, other lipoproteins and their constituents, apolipoproteins, may play an important role in atherosclerosis," scientists in Sweden explained.
"Elevated levels of apolipoprotein (apo) B, a constituent of atherogenic lipoproteins, and reduced levels of apo A-I, a component of anti-atherogenic HDL, are associated with increased cardiac events," according to G. Walldius and colleagues at AstraZeneca. "Apo B, apo A-I and the apo B/apo A-I ratio have been reported as better predictors...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Device Liability Week
More Articles from Cardiovascular Device Liability Week
- Environmental Health
Experts: EPA emissions plan harmful to health, North Carolina tourism - Johns Hopkins University
Public defibrillators: High-tech life-savers or expensive gimmicks? - Merit Medical Systems, Inc.
Disposable products maker reports record net income and revenue for 2003 - Tobacco Marketing
U.S. government tries to prove tobacco companies lured children - Acuity Pharmaceuticals
Cand5 inhibits blood vessel overgrowth and leakage in macular degeneration - Avant Immunotherapeutics, Inc.
Phase IIb study of TP10 in women undergoing bypass surgery initiated - More from this issue of Cardiovascular Device Liability Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
